With survival rates still low, NodeAI’s deep-learning tool could double the accuracy of a crucial cancer test — and cut costs ...

When the patient opted against surveillance CT scans and a follow-up PET scan, her physician ordered the CyPath® Lung test in March 2025. The test result of 0.56 – classified as “likely malignancy” – ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.

Group sales grew by 7%1 at constant exchange rates (CER; 4% in CHF), driven by strong demand for medicines.Pharmaceuticals Division sales rose by 10% (6% in CHF), with Phesgo (breast ...

Less radiation exposure during diagnosis and treatment for breast and lung cancer: New Fraunhofer method combines X-ray imaging and radar.